Free Trial

Quipt Home Medical (QIPT) Competitors

Quipt Home Medical logo
$3.01 +0.26 (+9.45%)
(As of 12/13/2024 ET)

QIPT vs. EHAB, DCGO, AIRS, VMD, PSNL, LFMD, SERA, BDSX, EUDA, and PIII

Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Enhabit (EHAB), DocGo (DCGO), AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Personalis (PSNL), LifeMD (LFMD), Sera Prognostics (SERA), Biodesix (BDSX), EUDA Health (EUDA), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry.

Quipt Home Medical vs.

Enhabit (NYSE:EHAB) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, Enhabit had 10 more articles in the media than Quipt Home Medical. MarketBeat recorded 12 mentions for Enhabit and 2 mentions for Quipt Home Medical. Quipt Home Medical's average media sentiment score of 1.82 beat Enhabit's score of 0.93 indicating that Quipt Home Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Enhabit
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quipt Home Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Quipt Home Medical received 27 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 83.78% of users gave Quipt Home Medical an outperform vote while only 14.29% of users gave Enhabit an outperform vote.

CompanyUnderperformOutperform
EnhabitOutperform Votes
4
14.29%
Underperform Votes
24
85.71%
Quipt Home MedicalOutperform Votes
31
83.78%
Underperform Votes
6
16.22%

Enhabit has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500.

Quipt Home Medical has a net margin of -1.95% compared to Enhabit's net margin of -11.24%. Enhabit's return on equity of 1.67% beat Quipt Home Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Enhabit-11.24% 1.67% 0.80%
Quipt Home Medical -1.95%-4.51%-2.01%

Enhabit presently has a consensus target price of $8.75, indicating a potential upside of 2.70%. Quipt Home Medical has a consensus target price of $6.25, indicating a potential upside of 107.64%. Given Quipt Home Medical's stronger consensus rating and higher probable upside, analysts clearly believe Quipt Home Medical is more favorable than Enhabit.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enhabit
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Quipt Home Medical
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

Quipt Home Medical has lower revenue, but higher earnings than Enhabit. Quipt Home Medical is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enhabit$1.04B0.41-$80.50M-$2.32-3.67
Quipt Home Medical$255.81M0.51-$2.78M-$0.11-27.36

42.8% of Quipt Home Medical shares are held by institutional investors. 1.9% of Enhabit shares are held by company insiders. Comparatively, 4.2% of Quipt Home Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Quipt Home Medical beats Enhabit on 13 of the 19 factors compared between the two stocks.

Get Quipt Home Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QIPT vs. The Competition

MetricQuipt Home MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$129.70M$4.42B$5.27B$9.27B
Dividend YieldN/A52.58%5.16%3.99%
P/E Ratio-27.3624.35105.7917.30
Price / Sales0.5143.691,346.91147.80
Price / Cash3.1857.1842.5838.47
Price / Book1.147.414.894.88
Net Income-$2.78M$13.70M$119.85M$225.52M
7 Day Performance11.90%0.19%17.72%-0.13%
1 Month Performance9.45%2.20%20.19%5.71%
1 Year Performance-32.05%55.88%37.87%21.42%

Quipt Home Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QIPT
Quipt Home Medical
2.4197 of 5 stars
$3.01
+9.5%
$6.25
+107.6%
-33.4%$129.70M$255.81M-27.361,200Positive News
EHAB
Enhabit
2.1473 of 5 stars
$8.91
+15.3%
$9.40
+5.5%
-22.5%$448.00M$1.05B-3.3310,800Insider Trade
News Coverage
DCGO
DocGo
2.5246 of 5 stars
$4.16
+2.0%
$6.10
+46.6%
-20.4%$424.53M$624.29M14.574,164
AIRS
AirSculpt Technologies
0.5595 of 5 stars
$6.27
-3.2%
$5.00
-20.3%
-13.5%$362.91M$195.92M0.00346Short Interest ↑
High Trading Volume
VMD
Viemed Healthcare
2.7177 of 5 stars
$8.61
-0.1%
N/A+17.6%$335.27M$183.01M33.33630Positive News
PSNL
Personalis
4.1727 of 5 stars
$4.03
-2.9%
$6.81
+69.0%
+172.9%$284.72M$73.48M0.00400Positive News
Gap Down
LFMD
LifeMD
2.364 of 5 stars
$5.82
+4.3%
$11.50
+97.6%
-24.9%$252.06M$152.55M-9.11230Analyst Forecast
Gap Up
SERA
Sera Prognostics
0.5227 of 5 stars
$7.37
+0.3%
N/A+75.2%$248.89M$310,000.000.00120
BDSX
Biodesix
3.3008 of 5 stars
$1.29
-4.4%
$3.06
+137.2%
-15.2%$187.66M$49.09M-3.41220Short Interest ↑
News Coverage
EUDA
EUDA Health
0.3822 of 5 stars
$4.66
+7.6%
N/A+392.5%$114.78M$3.71M0.002Short Interest ↑
PIII
P3 Health Partners
3.3211 of 5 stars
$0.23
-0.2%
$2.38
+929.0%
-80.4%$82.82M$1.27B-0.28500Short Interest ↓
News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:QIPT) was last updated on 12/14/2024 by MarketBeat.com Staff
From Our Partners